Global Medtech Guidance Tracker: June 2018
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-nine new guidance documents were posted on the tracker since its last update.
You may also be interested in...
The Singapore Health Sciences Authority says regulatory changes that will provide faster market access for class A and many class B devices kicked in on June 1. The requirements for telehealth devices and high-risk devices cosmetic devices have also been clarified.
India has proposed three categories for grouping genetically edited organisms based on the complexity of modifications.
Now that the UK has left the EU, the UK’s medicines regulator says it will use the rest of this year to work out how best to ensure continuity of drug regulation after the Brexit transition period ends on 31 December.